Technical Analysis for QPT - Quest Pharmatech Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 20.00% | |
| Wide Bands | Range Expansion | 20.00% | |
| Fell Below 20 DMA | Bearish | 20.00% | |
| Fell Below 50 DMA | Bearish | 20.00% | |
| Shooting Star Candlestick | Bearish | 20.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 20.00% | |
| Wide Range Bar | Range Expansion | 20.00% | |
| Doji - Bearish? | Reversal | 20.00% | |
| Earnings Movers | Other | 20.00% | |
| Outside Day | Range Expansion | 20.00% |
| Alert | Time |
|---|---|
| Upper Bollinger Band Resistance | 11 days ago |
| Reversed from Up | 11 days ago |
| 50 DMA Resistance | 11 days ago |
| 20 DMA Resistance | 11 days ago |
| 10 DMA Resistance | 11 days ago |
Get a Trading Sidekick!
- Earnings date: 2024-07-12
Quest Pharmatech Inc. Description
Quest PharmaTech Inc. is a Canada-based pharmaceutical company. The Company, through its subsidiary, OncoQuest Inc., is developing immunotherapies for cancer treatment. It operates through two segments: biopharmaceutical/pharmaceutical products and consumer/cosmetic products. OncoQuest's technology platform includes a panel of tumor antigen specific monoclonal immunoglobulins, including CA125, MUC1, PSA, and Her2/neu, and the application of combinatorial immunotherapy. OncoQuest's lead product, oregovomab, is undergoing a Phase IIb clinical trial involving approximately 80 ovarian cancer patients in Italy and the United States. OncoQuest's pipeline of product candidates consists of four other monoclonal antibodies targeting certain tumor antigens that are presented in a range of cancers, including such cancers as breast, lung, pancreas, stomach and prostate. It also markets consumer health products around the world, including Bellus Skin serum, an anti-wrinkle skin care product.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Medicine Pipe Pharma Pharmaceutical Pipeline Clinic Cancer RTT Skin Therapy Pharmaceutical Products Clinical Trial Biopharmaceutical Cancers Tumor Antigen Immunotherapy Treatment Of Cancer Antibodies Breast Cancer Consumer Health Products Cosmetic Products Immunotherapies Monoclonal Antibodies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.12 |
| 52 Week Low | 0.02 |
| Average Volume | 25,244 |
| 200-Day Moving Average | 0.058 |
| 50-Day Moving Average | 0.027 |
| 20-Day Moving Average | 0.026 |
| 10-Day Moving Average | 0.027 |
| Average True Range | 0.005 |
| RSI (14) | 48.72 |
| ADX | 8.56 |
| +DI | 48.696 |
| -DI | 33.913 |
| Chandelier Exit (Long, 3 ATRs) | 0.025 |
| Chandelier Exit (Short, 3 ATRs) | 0.035 |
| Upper Bollinger Bands | 0.033 |
| Lower Bollinger Band | 0.019 |
| Percent B (%b) | 0.45 |
| BandWidth | 56.589 |
| MACD Line | -0.001 |
| MACD Signal Line | -0.001 |
| MACD Histogram | 0.0006 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.025 | ||||
| Resistance 3 (R3) | 0.025 | 0.025 | 0.025 | ||
| Resistance 2 (R2) | 0.025 | 0.025 | 0.025 | 0.025 | |
| Resistance 1 (R1) | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 |
| Pivot Point | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 |
| Support 1 (S1) | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 |
| Support 2 (S2) | 0.025 | 0.025 | 0.025 | 0.025 | |
| Support 3 (S3) | 0.025 | 0.025 | 0.025 | ||
| Support 4 (S4) | 0.025 |
